FIELD: medicine, pharmaceutical industry.
SUBSTANCE: invention proposes a combined preparation containing valerian tincture, hawthorn tincture, motherwort tincture, peppermint tincture and dimedrol taken in the following ratio of components, wt.-%: valerian tincture, 32-34; hawthorn tincture, 32-34; motherwort tincture, 16-17; peppermint tincture, 16-17, and dimedrol, 0.1-0.2. The combined preparation is used in functional disorders of cardiovascular system, initial symptoms of stenocardia, initial form of arterial hypertension, paroxysmal tachycardia, extrasystolia, insomnia, enhanced irritability and neurosis. The preparation has no toxicity and characterized by minimal risk in development of adverse effects. Invention can be used in treatment of patients with cardiovascular insufficiency, cardiac stenocardia and neurosis.
EFFECT: valuable medicinal properties of preparation.
3 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
PHARMACEUTICAL COMPOSITION POSSESSING SEDATIVE AND SPASMOLYTIC ACTION | 2014 |
|
RU2535020C1 |
COMPOSITION SHOWING SEDATIVE EFFECT | 1998 |
|
RU2138280C1 |
COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR EXPRESS RELAXATION | 2016 |
|
RU2682888C2 |
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
PHARMACEUTICAL COMPOSITION WITH IMMUNOTROPIC AND ADAPTOGENIC ACTIVITY FOR ORAL USING | 2004 |
|
RU2275928C2 |
PREPARATION "KARDIOFIT" FOR TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | 1998 |
|
RU2137496C1 |
TINCTURE FROM AVENA SATIVA Z. OF MILK-WAX RIPENESS, METHOD FOR PRODUCTION THEREOF AND AGENTS BASED ON AVENA SATIVA Z. OF MILK-WAX RIPENESS | 2004 |
|
RU2282459C2 |
LIQUID SEDATIVE | 2021 |
|
RU2779256C1 |
PREPARATION FOR RECOVERY OF CARDIOVASCULAR SYSTEM, HAVING CARDIOPROTECTIVE, SEDATIVE AND HYPOTENSIVE ACTION | 2019 |
|
RU2704323C1 |
Authors
Dates
2007-03-27—Published
2004-06-11—Filed